Supernus Pharmaceuticals (SUPN) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to -$13.5 million.
- Supernus Pharmaceuticals' Other Gross PP&E Adjustments fell 17244.65% to -$13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.5 million, marking a year-over-year decrease of 17244.65%. This contributed to the annual value of -$6.1 million for FY2024, which is 4800.85% up from last year.
- Latest data reveals that Supernus Pharmaceuticals reported Other Gross PP&E Adjustments of -$13.5 million as of Q3 2025, which was down 17244.65% from -$7.8 million recorded in Q2 2025.
- Supernus Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $25.3 million during Q1 2021, with a 5-year trough of -$36.4 million in Q2 2022.
- In the last 5 years, Supernus Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$7.8 million in 2025 and averaged -$3.6 million.
- Data for Supernus Pharmaceuticals' Other Gross PP&E Adjustments shows a peak YoY increase of 17346.28% (in 2021) and a maximum YoY decrease of 25153.87% (in 2021) over the last 5 years.
- Over the past 5 years, Supernus Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$28.7 million in 2021, then skyrocketed by 39.11% to -$17.5 million in 2022, then soared by 32.87% to -$11.7 million in 2023, then surged by 48.01% to -$6.1 million in 2024, then tumbled by 121.65% to -$13.5 million in 2025.
- Its last three reported values are -$13.5 million in Q3 2025, -$7.8 million for Q2 2025, and $14.9 million during Q1 2025.